Altimmune’s Richardson Linda M exercised Options for 24,000 shares at $0 per share on September 16, 2026, while forfeiting 6,826 shares at $3.24. For investors tracking insider ownership, her resulting holdings were 17,174 shares and 72,000 derivative securities.
Key Highlights
- Richardson Linda M forfeited 6,826 Altimmune shares at $3.24 per share.
- Her derivative-security balance stood at 72,000 after the transaction.
- Richardson Linda M exercised options for 24,000 shares at $0 per share on September 16, 2026.
Altimmune, Inc. (NASDAQ: ALT) is a biotechnology company. Richardson Linda M, the company’s Chief Commercial Officer, exercised options for 24,000 shares at $0 per share on September 16, 2026. She also forfeited 6,826 shares at $3.24 per share on the same date. That forfeited amount represented about 28.4% of her prior share holding.
Derivative Securities After the Transactions
Richardson Linda M also exercised options covering 24,000 derivative securities of Altimmune. Her resulting balance was 72,000 derivative securities. The exercised derivative securities represented about 25.0% of her prior derivative-security holding.
FAQs
Q: How many Altimmune options did Richardson Linda M exercise?
A: Richardson Linda M exercised options for 24,000 Altimmune shares at $0 per share on September 16, 2026. The transaction used code M.
Q: What happened to Richardson Linda M’s Altimmune share holding?
A: Richardson Linda M forfeited 6,826 Altimmune shares at $3.24 per share.
Q: How many derivative securities did Richardson Linda M own after the transaction?
A: Richardson Linda M held 72,000 Altimmune derivative securities after exercising options for 24,000 derivative securities. The exercise represented about 25.0% of her prior holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.